Cargando…
Acquired hypermethylation of the P16(INK4A) promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
Recurrent alterations in promoter methylation of tumor suppressor genes (TSGs) and LINE1 (L1RE1) repeat elements were previously reported in pheochromocytoma and abdominal paraganglioma. This study was undertaken to explore CpG methylation abnormalities in an extended tumor panel and assess possible...
Autores principales: | Kiss, Nimrod B, Muth, Andreas, Andreasson, Adam, Juhlin, C Christofer, Geli, Janos, Bäckdahl, Martin, Höög, Anders, Wängberg, Bo, Nilsson, Ola, Ahlman, Håkan, Larsson, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Endocrinology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573842/ https://www.ncbi.nlm.nih.gov/pubmed/23154831 http://dx.doi.org/10.1530/ERC-12-0267 |
Ejemplares similares
-
The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
por: Andreasson, Adam, et al.
Publicado: (2013) -
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010) -
Prevalence of Germline Mutations in Patients with Pheochromocytoma or Abdominal Paraganglioma and Sporadic Presentation: A Population-Based Study in Western Sweden
por: Muth, Andreas, et al.
Publicado: (2012) -
Diffuse PTH expression in parathyroid tumors argues against important functional
tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016) -
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)